Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thymus Neoplasms × amrubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 5 Urinary Bladder Neoplasms 1 Thymus Neoplasms 1 Thymoma 1 Sarcoma 1 Neoplasm Metastasis 1 Breast Neoplasms 1

Interventions

ribociclib 1 pembrolizumab 1 palbociclib 1 epacadostat 1 amrubicin 1 Sunitinib 1 Erlotinib Hydrochloride 1 Drug Therapy 1 Cisplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01364727 2019-04-16

A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies

Stanford University

Phase 2 Completed

33 enrolled 11 charts

Thymoma, Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡